Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belotecan in previously treated NSCLC
NCT01022671Phase 2Completed
- Sponsor
- Chong Kun Dang Holdings
- Start
- Sep 2009
- Primary completion
- Feb 2010
- Modality
- Classical Binding Small Molecules
01
Overview
A Phase 2 trial of belotecan in non-small cell lung cancer (NSCLC), sponsored by Chong Kun Dang Holdings. Started Sep 2009; status: completed.
02
Drugs
belotecan
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01022671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01022671.